Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation

[1]  N. Philip,et al.  Mevalonic aciduria and hyper-IgD syndrome: Two sides of the same coin? , 2001, Journal of Inherited Metabolic Disease.

[2]  E. Mayatepek,et al.  Enhanced excretion of urinary leukotriene E4 in mevalonic aciduria is not caused by an impaired peroxisomal degradation of cysteinyl leukotrienes , 1997, Journal of Inherited Metabolic Disease.

[3]  Á. Haraldsson,et al.  Immunological studies in the hyper-immunoglobulin D syndrome , 1992, Journal of Clinical Immunology.

[4]  Sebastian Maurer-Stroh,et al.  Protein prenyltransferases , 2003, Genome Biology.

[5]  H. Waterham,et al.  Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands , 2003, European Journal of Human Genetics.

[6]  H. Waterham,et al.  Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. , 2002, Human molecular genetics.

[7]  H. Waterham,et al.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. , 2002, Arthritis and rheumatism.

[8]  G. Weitz-Schmidt,et al.  Statins as anti-inflammatory agents. , 2002, Trends in pharmacological sciences.

[9]  J. Auer,et al.  Clinical significance of pleiotropic effects of statins: lipid reduction and beyond. , 2002, Current medicinal chemistry.

[10]  A. Thatayatikom,et al.  Mutation of a New Gene Encoding a Putative Pyrin-Like Protein Causes Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome , 2002, Pediatrics.

[11]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[12]  J. Liao.  Isoprenoids as mediators of the biological effects of statins. , 2002, The Journal of clinical investigation.

[13]  A. Fischer,et al.  Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. , 2002, American journal of human genetics.

[14]  M. Schaller,et al.  Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. , 2002, Clinical and experimental rheumatology.

[15]  Rivka L. Glaser,et al.  Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. , 2002, American journal of medical genetics.

[16]  S. Srinivasula,et al.  The PYRIN-CARD Protein ASC Is an Activating Adaptor for Caspase-1* , 2002, The Journal of Biological Chemistry.

[17]  D. Scott,et al.  New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. , 2002, American journal of human genetics.

[18]  B. Guillois,et al.  An intestinal obstruction in an eight‐month‐old child suffering from mevalonic aciduria , 2002, Acta paediatrica.

[19]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[20]  Dong Yang,et al.  Structure of the Methanococcus jannaschii Mevalonate Kinase, a Member of the GHMP Kinase Superfamily* , 2002, The Journal of Biological Chemistry.

[21]  U. Laufs,et al.  Pleiotropic effects of HMG-CoA reductase inhibitors , 2002, Basic Research in Cardiology.

[22]  J. Meer,et al.  Hereditary periodic fever - Reply , 2002 .

[23]  A. Ballabio,et al.  Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. , 2002, American journal of human genetics.

[24]  G. Herman,et al.  Inborn errors of sterol biosynthesis. , 2003, Annual review of genomics and human genetics.

[25]  D. Kastner,et al.  A fever gene comes in from the cold , 2001, Nature Genetics.

[26]  L. Cuisset,et al.  Molecular Analysis of the Mevalonate Kinase Gene in a Cohort of Patients with the Hyper-IgD and Periodic Fever Syndrome: Its Application as a Diagnostic Tool , 2001, Annals of Internal Medicine.

[27]  V. Dixit,et al.  The PYRIN domain: A member of the death domain‐fold superfamily , 2001, Protein science : a publication of the Protein Society.

[28]  J. Meer,et al.  Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. , 2001, The Journal of pharmacology and experimental therapeutics.

[29]  H. Sone,et al.  Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. , 2001, Biochemical and biophysical research communications.

[30]  E. Mayatepek,et al.  Increased urinary leukotriene E4 during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome , 2001, Archives of disease in childhood.

[31]  N. Ridgway,et al.  Uncoupling Farnesol-induced Apoptosis from Its Inhibition of Phosphatidylcholine Synthesis* , 2001, The Journal of Biological Chemistry.

[32]  J. Pereira-Leal,et al.  Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease , 2001, FEBS letters.

[33]  R. Kelley,et al.  Inherited disorders of cholesterol biosynthesis. , 2001, Neuropediatrics.

[34]  H. Waterham,et al.  Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. , 2001, Rheumatology.

[35]  Y. Cho,et al.  Characterization of mevalonate kinase V377I, a mutant implicated in defective isoprenoid biosynthesis and HIDS/periodic fever syndrome. , 2001, Biochimica et biophysica acta.

[36]  H. Miziorko,et al.  Investigation of Invariant Serine/Threonine Residues in Mevalonate Kinase , 2001, The Journal of Biological Chemistry.

[37]  J. Meer,et al.  Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome , 2001, European Journal of Human Genetics.

[38]  H. Waterham,et al.  Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome , 2001, European Journal of Human Genetics.

[39]  F. Martinon,et al.  The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation , 2001, Current Biology.

[40]  J C Reed,et al.  PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. , 2001, Trends in biochemical sciences.

[41]  J. van der Meer,et al.  Hyper-Immunoglobulin A in the Hyperimmunoglobulinemia D Syndrome , 2001, Clinical Diagnostic Laboratory Immunology.

[42]  P. M. Davis,et al.  Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. , 2001, International immunopharmacology.

[43]  P. Beachy,et al.  Cholesterol modification of proteins. , 2000, Biochimica et biophysica acta.

[44]  D Tabor,et al.  Regulation of gene expression by SREBP and SCAP. , 2000, Biochimica et biophysica acta.

[45]  J. Auwerx,et al.  Sterols and gene expression: control of affluence. , 2000, Biochimica et biophysica acta.

[46]  T. Tansey,et al.  Structure and regulation of mammalian squalene synthase. , 2000, Biochimica et biophysica acta.

[47]  R. Wanders,et al.  Biochemical and genetic aspects of mevalonate kinase and its deficiency. , 2000, Biochimica et biophysica acta.

[48]  J. Bertin,et al.  The PYRIN domain: a novel motif found in apoptosis and inflammation proteins , 2000, Cell Death and Differentiation.

[49]  D. Harats,et al.  The Ubiquitin-Proteasome Pathway Mediates the Regulated Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase* , 2000, The Journal of Biological Chemistry.

[50]  T. Osborne,et al.  Sterol Regulatory Element-binding Proteins (SREBPs): Key Regulators of Nutritional Homeostasis and Insulin Action* , 2000, The Journal of Biological Chemistry.

[51]  R. Pardi,et al.  Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein1 , 2000, The Journal of Immunology.

[52]  D. Kastner,et al.  TNFRSF1A mutations and autoinflammatory syndromes. , 2000, Current opinion in immunology.

[53]  A. Munnich,et al.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.

[54]  H. Waterham,et al.  Mevalonate kinase deficiency and Dutch type periodic fever. , 2000, Clinical and experimental rheumatology.

[55]  A. Munnich,et al.  A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. , 2000, Human molecular genetics.

[56]  G. Prendergast,et al.  Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects. , 2000, Current opinion in cell biology.

[57]  A. Vladutiu.  Immunoglobulin D: Properties, Measurement, and Clinical Relevance , 2000, Clinical Diagnostic Laboratory Immunology.

[58]  K. Grzeschik,et al.  Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. , 2000, American journal of medical genetics.

[59]  N. Braverman,et al.  CHILD syndrome caused by deficiency of 3beta-hydroxysteroid-delta8, delta7-isomerase. , 2000, American journal of medical genetics.

[60]  R. Kelley,et al.  Inborn errors of cholesterol biosynthesis. , 2003 .

[61]  J. Maul,et al.  Farnesol is utilized for isoprenoid biosynthesis in plant cells via farnesyl pyrophosphate formed by successive monophosphorylation reactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Brown,et al.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Rolland,et al.  Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. , 1999, American journal of human genetics.

[64]  H. Waterham,et al.  Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. , 1999, Human molecular genetics.

[65]  U. Laufs,et al.  3-Hydroxy-3-methylglutaryl-CoA Reductase Inhibitors Attenuate Vascular Smooth Muscle Proliferation by Preventing Rho GTPase-induced Down-regulation of p27 Kip1 * , 1999, The Journal of Biological Chemistry.

[66]  H. Waterham,et al.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.

[67]  Joost P.H. Drenth,et al.  Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome , 1999, Nature Genetics.

[68]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[69]  K. Gibson,et al.  Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. , 1999, Journal of lipid research.

[70]  A. Moser,et al.  Abnormal sterol metabolism in patients with Conradi-Hünermann-Happle syndrome and sporadic lethal chondrodysplasia punctata. , 1999, American journal of medical genetics.

[71]  J. Derry,et al.  Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. , 1999, Nature genetics.

[72]  A. Moser,et al.  Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. , 1999, Nature genetics.

[73]  E. Lelièvre,et al.  T(h)2 cytokine dependence of IgD production by normal human B cells. , 1999, International immunology.

[74]  G. Favre,et al.  Competitive Inhibition of Choline Phosphotransferase by Geranylgeraniol and Farnesol Inhibits Phosphatidylcholine Synthesis and Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells* , 1998, The Journal of Biological Chemistry.

[75]  K. Gibson,et al.  Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency. , 1998, American journal of medical genetics.

[76]  E. Swiezewska,et al.  Phosphorylation of farnesol in rat liver microsomes: properties of farnesol kinase and farnesyl phosphate kinase. , 1998, Archives of biochemistry and biophysics.

[77]  K. Gibson,et al.  Characterization of the mevalonate kinase 5'-untranslated region provides evidence for coordinate regulation of cholesterol biosynthesis. , 1998, Biochemical and biophysical research communications.

[78]  R. Winter,et al.  Clinical phenotype of desmosterolosis. , 1998, American journal of medical genetics.

[79]  K. Gibson,et al.  Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways. , 1997, Journal of lipid research.

[80]  B. Levy,et al.  Polyisoprenyl phosphates in intracellular signalling , 1997, Nature.

[81]  K. Gibson,et al.  Identification of an Active Site Alanine in Mevalonate Kinase through Characterization of a Novel Mutation in Mevalonate Kinase Deficiency* , 1997, The Journal of Biological Chemistry.

[82]  H. Miziorko,et al.  Identification of Catalytic Residues in Human Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[83]  R. D. Simoni,et al.  Farnesol as a regulator of HMG-CoA reductase degradation: characterization and role of farnesyl pyrophosphatase. , 1997, Archives of biochemistry and biophysics.

[84]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[85]  K. Feingold,et al.  Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters. , 1997, Journal of lipid research.

[86]  S. Krisans,et al.  Cloning and Subcellular Localization of Hamster and Rat Isopentenyl Diphosphate Dimethylallyl Diphosphate Isomerase , 1997, The Journal of Biological Chemistry.

[87]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[88]  J. D. Karkas,et al.  Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol* , 1997, The Journal of Biological Chemistry.

[89]  K. Gibson,et al.  Regulatory Adaptation of Isoprenoid Biosynthesis and the LDL Receptor Pathway in Fibroblasts from Patients with Mevalonate Kinase Deficiency , 1997, Pediatric Research.

[90]  H. Miziorko,et al.  Identification and Functional Characterization of an Active-site Lysine in Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[91]  N. Aboushadi,et al.  Metabolism of farnesol: phosphorylation of farnesol by rat liver microsomal and peroxisomal fractions. , 1997, Biochemical and biophysical research communications.

[92]  B. Buckley,et al.  Statins do more than just lower cholesterol , 1996, The Lancet.

[93]  M. Schwemmle,et al.  Prenylation of an interferon‐γ‐induced GTP‐binding protein: the human guanylate binding protein, huGBP1 , 1996, Journal of leukocyte biology.

[94]  G. Favre,et al.  Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. , 1996, Biochemical and biophysical research communications.

[95]  M. Daha,et al.  Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.

[96]  J. V. D. van der Meer,et al.  Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. , 1996, Journal of immunology.

[97]  G. Ness,et al.  Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. , 1996, Archives of biochemistry and biophysics.

[98]  R. D. Simoni,et al.  Regulation of 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Degradation by the Nonsterol Mevalonate Metabolite Farnesol in Vivo(*) , 1996, The Journal of Biological Chemistry.

[99]  B. Kasiske,et al.  Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? , 1996, The Lancet.

[100]  J. Meer,et al.  Interferon‐γ and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome , 1995, European journal of clinical investigation.

[101]  J. V. D. van der Meer,et al.  Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation. , 1995, Clinical immunology and immunopathology.

[102]  K. Feingold,et al.  Discordant regulation of proteins of cholesterol metabolism during the acute phase response. , 1995, Journal of lipid research.

[103]  D. Andres,et al.  Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells. , 1995, Biochemical and biophysical research communications.

[104]  C. Schalkwijk,et al.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. , 1995, Blood.

[105]  D. Andres,et al.  Utilization of geranylgeraniol for protein isoprenylation in C6 glial cells. , 1994, Biochemical and biophysical research communications.

[106]  P. Edwards,et al.  Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1994, The Journal of biological chemistry.

[107]  J. V. D. van der Meer,et al.  Hyperimmunoglobulinemia D and Periodic Fever Syndrome: The Clinical Spectrum in a Series of 50 Patients , 1994, Medicine.

[108]  R. D. Simoni,et al.  Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels. , 1994, The Journal of biological chemistry.

[109]  P. Edwards,et al.  Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. , 1994, The Journal of biological chemistry.

[110]  V. Bansal,et al.  Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes. , 1994, Archives of biochemistry and biophysics.

[111]  J. Taylor,et al.  Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. , 1993, Journal of lipid research.

[112]  K. Gibson,et al.  Bile acid metabolism in three patients with mevalonic aciduria due to mevalonate kinase deficiency. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[113]  H. Lehr,et al.  Decreased Plasma Ubiquinone-10 Concentration in Patients with Mevalonate Kinase Deficiency , 1993, Pediatric Research.

[114]  H. Bremer,et al.  Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency. , 1993, The Journal of pediatrics.

[115]  G. Tint,et al.  Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome , 1993, The Lancet.

[116]  R. Parker,et al.  Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1993, The Journal of biological chemistry.

[117]  J. D. Karkas,et al.  Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[118]  K. Gibson,et al.  Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria. , 1992, The Journal of biological chemistry.

[119]  R. Evans,et al.  Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. , 1990, The Journal of biological chemistry.

[120]  K. Gibson,et al.  3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium. , 1990, Journal of lipid research.

[121]  R. Tanaka,et al.  Purification and regulation of mevalonate kinase from rat liver. , 1990, The Journal of biological chemistry.

[122]  M. Nakanishi,et al.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. , 1988, The Journal of biological chemistry.

[123]  W. S. Simonet,et al.  Near normal levels of isoprenoid lipids in severe mevalonic aciduria. , 1988, Biochemical and biophysical research communications.

[124]  G. Hoffman.  Mevalonic aciduria. , 1988, Hepatology.

[125]  H. Schierbeek,et al.  Mevalonic aciduria: an inborn error of cholesterol biosynthesis? , 1985, Clinica chimica acta; international journal of clinical chemistry.

[126]  R. Furth,et al.  HYPERIMMUNOGLOBULINAEMIA D AND PERIODIC FEVER: A NEW SYNDROME , 1984, The Lancet.

[127]  C. Griscelli,et al.  [Nosologic aspects of systemic forms of very-early-onset juvenile arthritis. Apropos of 17 cases]. , 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[128]  C. Griscelli,et al.  [Nosologic aspects of systemic forms of very early onset juvenile arthritis. Apropos of 17 cases]. , 1983, Annales de pediatrie.

[129]  P. Edwards,et al.  Properties of purified rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and regulation of enzyme activity. , 1980, The Journal of biological chemistry.

[130]  P. Voûte,et al.  A description of two brothers with permanently raised non-esterified aetiocholanolone blood level. , 1968, Acta endocrinologica.

[131]  A. E. Russell,et al.  Preputial gland tumor sterols. 3. A metabolic pathway from lanosterol to cholesterol. , 1960, The Journal of biological chemistry.